Brandner S, McAleenan A, Kelly C, Spiga F, et al. MGMT promoter methylation testing to predict overall survival in people with glioblastoma treated with temozolomide: a comprehensive meta-analysis based on a Cochrane Review. Neuro Oncol 2021 Apr 30. pii: 6263562. doi: 10.1093.
PMID: 33942105